KTB Insider Jennifer Broyles Sells Shares
Jennifer Broyles sold 4,000 shares of KTB, netting $324,080.
Key Points
- Jennifer Broyles, EVP at KTB, sold 4,000 shares for $324,080 on June 12, 2026.
- KTB shares are trading at $79.01, with a market outlook bolstered by analyst targets up to $131.
- Institutional investors like BlackRock and Vanguard have adjusted their positions in KTB recently.
Jennifer Broyles, Executive Vice President and Global Brands President at KTB, sold 4,000 shares of the company on June 12, 2026. The shares were sold at an average price of $81.02, bringing the total transaction value to $324,080. This sale was not part of a pre-planned trading program.
Other Institutional Activity in KTB
BlackRock, Inc. increased its stake in KTB by 98,013 shares, now holding 7,861,544 shares valued at approximately $552.6 million. PNC Financial Services Group, Inc. reduced its holdings by 745,573 shares, leaving it with 6,016,648 shares worth about $422.9 million. Meanwhile, Vanguard Portfolio Management LLC and Vanguard Capital Management LLC both established new positions, each acquiring 3,323,794 and 2,442,349 shares, respectively, valued at $233.6 million and $171.7 million. JPMorgan Chase & Co also trimmed its stake by 444,886 shares, now holding 2,574,318 shares valued at $170.5 million.
Insider Buying and Selling at Kontoor Brands, Inc.
In addition to Broyles' recent sale, other insider activity includes several purchases on May 1, 2026. Mark Schiller, Shelley Jr. Stewart, Robert Shearer, Ashley Goldsmith, and MaryElizabeth Campbell each bought 2,236 shares at a price not disclosed, indicating ongoing interest among company insiders.
Analysts Set New Price Targets
On June 8, 2026, JP Morgan initiated coverage on KTB with a 'buy' rating and a price target of $90. Barclays maintained its 'buy' rating with a target of $96 on May 11, 2026. Earlier, several firms including Goldman Sachs, UBS, and Wells Fargo reaffirmed their 'buy' ratings with targets ranging from $95 to $131.
Bottom Line
The insider sale by Jennifer Broyles is a notable transaction, but it doesn't necessarily indicate a negative outlook for KTB. Institutional investors continue to adjust their positions, with some increasing their stakes significantly. Analysts remain optimistic, with several high price targets suggesting confidence in the company's future performance. As always, remember that insider and institutional trades are disclosed after the fact and may not reflect current positions.
See Also
This instant news alert was generated by automated narrative technology and financial data from EarningsIQ and public regulatory filings. It is for informational purposes only and is not financial advice.